The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling
Katrin Merk-Ahmad(Goethe University Frankfurt), Sylvia Hartmann(National Center for Tumor Diseases), Andreas Loth(Goethe University Frankfurt), Evelyn Ullrich(Goethe University Frankfurt), Hendrik Schäfer(University of Duisburg-Essen), Emmanuel Donnadieu(Centre National de la Recherche Scientifique), Julia Bein(Goethe University Frankfurt), Tobias Bexte(Goethe University Frankfurt), Tina Senff(Helios Universitätsklinikum Wuppertal), Matthieu Piel(Centre National de la Recherche Scientifique), Björn Häupl(Goethe University Frankfurt), Nadine Flinner(Goethe University Frankfurt), Martin‐Leo Hansmann(Goethe University Frankfurt), Sonja Scharf(University of Duisburg-Essen), Olga Schneider(Goethe University Frankfurt), Thomas Oellerich(Goethe University Frankfurt)
Cited by 1
Related Papers
Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors
|Journal of Clinical Investigation|2012|1.1k
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
|JAMA Oncology|2021|349
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
|Nature Medicine|2016|185